Androgens and Severe Insulin Resistance States: Basic and Clinical Aspects

Area of Science:

• Endocrinology
• Metabolic Disorders
• Genetics

Background:

• Hyperandrogenism, with or without polycystic ovary syndrome, can be a secondary condition driven by extreme insulin resistance (IR).
• Severe IR often stems from adipose tissue dysfunction, either through deficiency (lipodystrophies) or excessive accumulation.
• These conditions can arise from single-gene defects.

Purpose of the Study:

• To highlight the clinical significance of secondary hyperandrogenism caused by severe insulin resistance.
• To emphasize the importance of recognizing and diagnosing these often-underestimated conditions.
• To inform clinicians about the potential for tailored therapies.

Main Methods:

• Diagnosis relies primarily on clinical examination for hallmark signs.
• Biochemical biomarkers support the clinical assessment.
• Gene screening is utilized for corroborating specific diagnoses.

Main Results:

• Severe insulin resistance is a frequent cause of secondary hyperandrogenism.
• Adipose tissue dysfunction is the most common underlying mechanism.
• Certain forms of this condition are treatable with specific therapies.

Conclusions:

• Clinicians managing hyperandrogenic disorders must be aware of secondary forms due to severe IR.
• These conditions are more common than often perceived.
• Prompt diagnosis facilitates effective, tailored treatment strategies.